Aptorum Group Ltd - Ordinary Shares - Class A

NASDAQ:APM   10:36:02 AM EDT
2.64
0.00 (0.00%)
Earnings Announcements

Aptorum Group Announces Further Positive Interim Results Of Phase 1 Clinical Trial Of ALS-4

Published: 07/12/2021 12:20 GMT
Aptorum Group Ltd - Ordinary Shares - Class A (APM) - Aptorum Group Announces Further Positive Interim Results of the Phase 1 Clinical Trial of Als-4 Targeting Staphylococcus Aureus.